Plan sponsors are often tempted to reduce employee health benefits costs by implementing drug plan designs that restrict access to some medications. But a growing number of companies are recognizing that integrating comprehensive drug benefits with wellness programming can improve the health and productivity of the workforce and, ultimately, the company’s bottom line.
Let’s Think: Healthy Returns from Integrated Employee Health Benefits, sponsored by GSK, discusses which factors are contributing to total employee health outcomes and costs. The report assesses the real costs of medications, the consequences of restrictive drug plan designs, and the value of workplace health management and disease prevention programs.
Plan sponsors have many options available for ensuring that employees are as healthy as possible. Find out why now is the perfect time for employers to make important investments in workplace health management and disease prevention, and how a strategic health focus can drive significant shared benefits to employers and employees alike.